Background. Genome-wide association studies hold substantial promise for identifying common genetic variants that regulate susceptibility to complex diseases. However, for the detection of small genetic effects, single studies may be underpowered. Power may be improved by combining genome-wide datasets with meta-analytic techniques. Methodology/Principal Findings. Both single and two-stage genome-wide data may be combined and there are several possible strategies. In the two-stage framework, we considered the options of (1) enhancement of replication data and (2) enhancement of firststage data, and then, we also considered (3) joint meta-analyses including all first-stage and second-stage data. These strategies were examined empirically usi...
Background: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope o...
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common s...
BACKGROUND: Genome-wide association studies (GWAS) for Parkinson's disease have linked two loci ...
BACKGROUND: Genome-wide association studies hold substantial promise for identifying common genetic ...
International audienceEarly genome-wide association (GWA) studies on Parkinson's disease (PD) have n...
Early genome-wide association (GWA) studies on Parkinson's disease (PD) have not been able to yield ...
Early genome-wide association (GWA) studies on Parkinson's disease (PD) have not been able to yield ...
We conducted a meta analysis of Parkinson’s disease genome-wide association studies using a common s...
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common s...
<div><p>More than 800 published genetic association studies have implicated dozens of potential risk...
Background: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope o...
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common s...
BACKGROUND: Genome-wide association studies (GWAS) for Parkinson's disease have linked two loci ...
BACKGROUND: Genome-wide association studies hold substantial promise for identifying common genetic ...
International audienceEarly genome-wide association (GWA) studies on Parkinson's disease (PD) have n...
Early genome-wide association (GWA) studies on Parkinson's disease (PD) have not been able to yield ...
Early genome-wide association (GWA) studies on Parkinson's disease (PD) have not been able to yield ...
We conducted a meta analysis of Parkinson’s disease genome-wide association studies using a common s...
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common s...
<div><p>More than 800 published genetic association studies have implicated dozens of potential risk...
Background: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope o...
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common s...
BACKGROUND: Genome-wide association studies (GWAS) for Parkinson's disease have linked two loci ...